Interested in attending? Have a suggestion about running this course near you?
Register your interest now
Description
The new FRS 109 Financial Instruments is complex and will have a considerable impact on financial performance, operations and computer systems especially in relation to the new impairment requirements.
This webinar will go through the requirements of FRS 109 in relation to Financial Liabilities (excluding hedge accounting) and will provide many real-life examples on the impact of the standard. You will also get a good understanding on how to use the new impairment model to measure expected credit losses (ECL).
Programme Outline
Classification of financial liabilities
- Financial liabilities as subsequently measured at amortised cost
- Financial liabilities at fair value through profit or loss
The new impairment model
- The new 3 step model for measurement of expected credit losses
- Recognition of expected credit losses for assets measured at FVTOCI
- Simplified approach for trade receivables, contract assets and lease receivables
Examples explaining how the impairment is computed for an impaired receivable and accounting entries passed thereon.
This workshop qualifies for 2.5 CPE hours in Financial Reporting Standards and Pronouncements (Category 1).
What you will learn
Have a practical understanding of how to use the new impairment model to measure expected credit losses (ECL).
Target Audience
Accountants and Auditors
Expert Speaker
Sardool Singh
Sardool is an Adjunct Associate Professor in the Department of Accounting of the NUS Business School. He has been lecturing for the past 20 years, and is a highly sought-after seminar leader in the areas of Financial Reporting Standards, Cash Flow Statements, Analysis of Financial Statements, Consolidation and other technical accounting topics. Sardool brings a commercial perspective to the understanding of complex Accounting Standards and simplifies the requirements of these Standards to enable the participants to have a clear understanding of the topic.
Sardool is also the Chief Financial Officer of an investment company. Prior to his current appointment, he was the Group Financial Controller of a Singapore listed healthcare company. During his ten years in the healthcare industry, he was responsible for the entire Group financial functions and the IPOs of two subsidiaries on SESDAQ. He had also gained his working experience with KPMG Peat Marwick and a Japanese merchant bank.